Review



alexa fluor 647 anti human cd30  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 91
      Buy from Supplier

    Structured Review

    Novus Biologicals alexa fluor 647 anti human cd30
    Number of cells analyzed in the different cases.
    Alexa Fluor 647 Anti Human Cd30, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/alexa+fluor+647+anti+human+cd30/Human+CD30+Ligand%2FTNFSF8+Alexa+Fluor%C2%AE+647-conjugated+Antibody/pmc08534096-51-26-32
    Average 91 stars, based on 1 article reviews
    alexa fluor 647 anti human cd30 - by Bioz Stars, 2026-09
    91/100 stars

    Images

    1) Product Images from "Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas"

    Article Title: Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas

    Journal: Cancers

    doi: 10.3390/cancers13205208

    Number of cells analyzed in the different cases.
    Figure Legend Snippet: Number of cells analyzed in the different cases.

    Techniques Used:

    Velocity of different cell types under reactive and neoplastic conditions. ( a ). Velocity of PD1-positive T cells, CD20-positive B cells and CD30-positive cells in all cases studied (*** p < 0.001, one-way-ANOVA with Bonferroni’s post-test for multiple comparisons). Each dot represents the mean from one movie. ( b ). Velocity of CD20-positive B cells in lymphadenitis and malignant lymphomas. The velocity of bulk CD20-positive B cells in CD20+ lymphomas largely represents the velocity of tumor cells, whereas the velocity in CD20- lymphomas corresponds to reactive bystander B cells. (** p = 0.0042, unpaired t -test.) Each dot represents the mean from one movie. ( c ). Velocity of CD20-positive B cells listed according to different lymphoma entities. No significant differences were observed. Each dot represents the mean from one movie. Lymphadenitis: 4 cases, AITL, DLBCL and MCL: one case, MGZL and NLPHL: two cases, cHL: three cases. ( d ). Velocity of PD1-positive T cells grouped according to diagnosis of lymphadenitis, mature B-cell lymphomas and Hodgkin lymphomas. Each dot represents the mean from one movie. * p < 0.05, ** p < 0.01, Kruskal–Wallis test with Dunn’s post-test for multiple comparisons. ( e ). Velocity of PD1-positive T cells according to lymphoma entities. ** p < 0.01, *** p < 0.001, Kruskal–Wallis-Test with Dunn´s post-test for multiple comparisons. Each dot represents the mean from one movie. Lymphadenitis: 5 cases, AITL and MCL: one case, MGZL, DLBCL, FL and NLPHL: two cases, cHL: three cases. ( f ). Velocity of CD30-positive lymphoma cells compared with CD30-positive reactive bystander cells in CD30-negative lymphomas and lymphadenitis (* p < 0.05, unpaired t -test). Each dot represents the mean from one movie.
    Figure Legend Snippet: Velocity of different cell types under reactive and neoplastic conditions. ( a ). Velocity of PD1-positive T cells, CD20-positive B cells and CD30-positive cells in all cases studied (*** p < 0.001, one-way-ANOVA with Bonferroni’s post-test for multiple comparisons). Each dot represents the mean from one movie. ( b ). Velocity of CD20-positive B cells in lymphadenitis and malignant lymphomas. The velocity of bulk CD20-positive B cells in CD20+ lymphomas largely represents the velocity of tumor cells, whereas the velocity in CD20- lymphomas corresponds to reactive bystander B cells. (** p = 0.0042, unpaired t -test.) Each dot represents the mean from one movie. ( c ). Velocity of CD20-positive B cells listed according to different lymphoma entities. No significant differences were observed. Each dot represents the mean from one movie. Lymphadenitis: 4 cases, AITL, DLBCL and MCL: one case, MGZL and NLPHL: two cases, cHL: three cases. ( d ). Velocity of PD1-positive T cells grouped according to diagnosis of lymphadenitis, mature B-cell lymphomas and Hodgkin lymphomas. Each dot represents the mean from one movie. * p < 0.05, ** p < 0.01, Kruskal–Wallis test with Dunn’s post-test for multiple comparisons. ( e ). Velocity of PD1-positive T cells according to lymphoma entities. ** p < 0.01, *** p < 0.001, Kruskal–Wallis-Test with Dunn´s post-test for multiple comparisons. Each dot represents the mean from one movie. Lymphadenitis: 5 cases, AITL and MCL: one case, MGZL, DLBCL, FL and NLPHL: two cases, cHL: three cases. ( f ). Velocity of CD30-positive lymphoma cells compared with CD30-positive reactive bystander cells in CD30-negative lymphomas and lymphadenitis (* p < 0.05, unpaired t -test). Each dot represents the mean from one movie.

    Techniques Used: Biomarker Discovery

    Cell tracks according to different lymphoma types superimposed on fluorescence images. ( a – c ) Tracks of the tumor cells of mantle cell lymphoma ( a ), NLPHL ( b ) and MGZL ( c ) in CD20- or CD30-immunostaining, as indicated. Color of tracks corresponds to the observed velocity as indicated in the scale. ( d – f ) Tracks of the bystander T cells of the same cases: mantle cell lymphoma ( d ), NLPHL ( e ) and MGZL ( f ) in PD1-staining. Color of tracks corresponds to the observed velocity as indicated in the scale. ( g ) HE staining (200x) of the mantle cell lymphoma from ( a , d ). ( h ) HE staining (200x) of the NLPHL from ( b , e ). ( i ) HE staining (200×) of the MGZL from ( c , f ).
    Figure Legend Snippet: Cell tracks according to different lymphoma types superimposed on fluorescence images. ( a – c ) Tracks of the tumor cells of mantle cell lymphoma ( a ), NLPHL ( b ) and MGZL ( c ) in CD20- or CD30-immunostaining, as indicated. Color of tracks corresponds to the observed velocity as indicated in the scale. ( d – f ) Tracks of the bystander T cells of the same cases: mantle cell lymphoma ( d ), NLPHL ( e ) and MGZL ( f ) in PD1-staining. Color of tracks corresponds to the observed velocity as indicated in the scale. ( g ) HE staining (200x) of the mantle cell lymphoma from ( a , d ). ( h ) HE staining (200x) of the NLPHL from ( b , e ). ( i ) HE staining (200×) of the MGZL from ( c , f ).

    Techniques Used: Fluorescence, Immunostaining, Staining

    Cell–cell contacts between tumor and bystander cells. ( a ) Number of cell–cell contacts per movie between tumor cells (CD20 or CD30 as indicated) and PD1-positive T cells (for AITL PD1-positive tumor cells and CD20-positive B cells). Each dot represents the mean from one movie. Lymphadenitis: 4 cases, AITL, DLBCL, NLPHL and MCL: one case, MGZL: two cases, cHL: three cases. ( b ) Duration of cell–cell contacts between tumor (CD20 or CD30 as indicated) and PD1-positive T cells (for AITL PD1-positive tumor cells and CD20-positive B cells, * p < 0.05, Kruskal–Wallis test with Dunn’s post-test for multiple comparisons). Each dot represents the mean from one movie. Lymphadenitis: 4 cases, AITL, DLBCL, NLPHL and MCL: one case, MGZL: two cases, cHL: three cases.
    Figure Legend Snippet: Cell–cell contacts between tumor and bystander cells. ( a ) Number of cell–cell contacts per movie between tumor cells (CD20 or CD30 as indicated) and PD1-positive T cells (for AITL PD1-positive tumor cells and CD20-positive B cells). Each dot represents the mean from one movie. Lymphadenitis: 4 cases, AITL, DLBCL, NLPHL and MCL: one case, MGZL: two cases, cHL: three cases. ( b ) Duration of cell–cell contacts between tumor (CD20 or CD30 as indicated) and PD1-positive T cells (for AITL PD1-positive tumor cells and CD20-positive B cells, * p < 0.05, Kruskal–Wallis test with Dunn’s post-test for multiple comparisons). Each dot represents the mean from one movie. Lymphadenitis: 4 cases, AITL, DLBCL, NLPHL and MCL: one case, MGZL: two cases, cHL: three cases.

    Techniques Used:

    Related Articles

    Staining:

    Article Title: Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas
    Article Snippet: .. Live vibratome sections were stained for 15 min at 37 °C with the following antibodies: Alexa Fluor 647–anti-human PD-1 (clone EH12.2H7; BioLegend, San Diego, CA, USA), Alexa Fluor 647–anti-human CD30 (clone CD30/412, Novus Biologicals, Centennial, CO, USA), Alexa Fluor 488–anti-human PD-1 (clone EH12.2H7; BioLegend), Alexa Fluor 647–anti-human CD3 (clone UCHT1; BD Biosciences), Brilliant Violet 421–anti-human CD3 (clone UCHT1; BioLegend), Alexa Fluor 488–anti-human CD19 (clone HIB 19; BioLegend), Pacific Blue–anti-human CD20 (clone 2H7; BioLegend), Alexa Fluor 555-anti-human CD20 (polyclonal rabbit antibody; Bioss Antibodies, Woburn, MA, USA), and Alexa Fluor 555-anti-human CD19 (polyclonal rabbit antibody; Bioss Antibodies). ..



    Similar Products

    alexa fluor 647 anti human cd30  (Novus Biologicals)
    91
    Novus Biologicals alexa fluor 647 anti human cd30
    Number of cells analyzed in the different cases.
    Alexa Fluor 647 Anti Human Cd30, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/alexa+fluor+647+anti+human+cd30/Human+CD30+Ligand%2FTNFSF8+Alexa+Fluor%C2%AE+647-conjugated+Antibody/pmc08534096-51-26-32
    Average 91 stars, based on 1 article reviews
    alexa fluor 647 anti human cd30 - by Bioz Stars, 2026-09
    91/100 stars
    		  Buy from Supplier

    Image Search Results


    Number of cells analyzed in the different cases.

    Journal: Cancers

    Article Title: Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas

    doi: 10.3390/cancers13205208

    Figure Lengend Snippet: Number of cells analyzed in the different cases.

    Article Snippet: Live vibratome sections were stained for 15 min at 37 °C with the following antibodies: Alexa Fluor 647–anti-human PD-1 (clone EH12.2H7; BioLegend, San Diego, CA, USA), Alexa Fluor 647–anti-human CD30 (clone CD30/412, Novus Biologicals, Centennial, CO, USA), Alexa Fluor 488–anti-human PD-1 (clone EH12.2H7; BioLegend), Alexa Fluor 647–anti-human CD3 (clone UCHT1; BD Biosciences), Brilliant Violet 421–anti-human CD3 (clone UCHT1; BioLegend), Alexa Fluor 488–anti-human CD19 (clone HIB 19; BioLegend), Pacific Blue–anti-human CD20 (clone 2H7; BioLegend), Alexa Fluor 555-anti-human CD20 (polyclonal rabbit antibody; Bioss Antibodies, Woburn, MA, USA), and Alexa Fluor 555-anti-human CD19 (polyclonal rabbit antibody; Bioss Antibodies).

    Techniques:

    Velocity of different cell types under reactive and neoplastic conditions. ( a ). Velocity of PD1-positive T cells, CD20-positive B cells and CD30-positive cells in all cases studied (*** p < 0.001, one-way-ANOVA with Bonferroni’s post-test for multiple comparisons). Each dot represents the mean from one movie. ( b ). Velocity of CD20-positive B cells in lymphadenitis and malignant lymphomas. The velocity of bulk CD20-positive B cells in CD20+ lymphomas largely represents the velocity of tumor cells, whereas the velocity in CD20- lymphomas corresponds to reactive bystander B cells. (** p = 0.0042, unpaired t -test.) Each dot represents the mean from one movie. ( c ). Velocity of CD20-positive B cells listed according to different lymphoma entities. No significant differences were observed. Each dot represents the mean from one movie. Lymphadenitis: 4 cases, AITL, DLBCL and MCL: one case, MGZL and NLPHL: two cases, cHL: three cases. ( d ). Velocity of PD1-positive T cells grouped according to diagnosis of lymphadenitis, mature B-cell lymphomas and Hodgkin lymphomas. Each dot represents the mean from one movie. * p < 0.05, ** p < 0.01, Kruskal–Wallis test with Dunn’s post-test for multiple comparisons. ( e ). Velocity of PD1-positive T cells according to lymphoma entities. ** p < 0.01, *** p < 0.001, Kruskal–Wallis-Test with Dunn´s post-test for multiple comparisons. Each dot represents the mean from one movie. Lymphadenitis: 5 cases, AITL and MCL: one case, MGZL, DLBCL, FL and NLPHL: two cases, cHL: three cases. ( f ). Velocity of CD30-positive lymphoma cells compared with CD30-positive reactive bystander cells in CD30-negative lymphomas and lymphadenitis (* p < 0.05, unpaired t -test). Each dot represents the mean from one movie.

    Journal: Cancers

    Article Title: Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas

    doi: 10.3390/cancers13205208

    Figure Lengend Snippet: Velocity of different cell types under reactive and neoplastic conditions. ( a ). Velocity of PD1-positive T cells, CD20-positive B cells and CD30-positive cells in all cases studied (*** p < 0.001, one-way-ANOVA with Bonferroni’s post-test for multiple comparisons). Each dot represents the mean from one movie. ( b ). Velocity of CD20-positive B cells in lymphadenitis and malignant lymphomas. The velocity of bulk CD20-positive B cells in CD20+ lymphomas largely represents the velocity of tumor cells, whereas the velocity in CD20- lymphomas corresponds to reactive bystander B cells. (** p = 0.0042, unpaired t -test.) Each dot represents the mean from one movie. ( c ). Velocity of CD20-positive B cells listed according to different lymphoma entities. No significant differences were observed. Each dot represents the mean from one movie. Lymphadenitis: 4 cases, AITL, DLBCL and MCL: one case, MGZL and NLPHL: two cases, cHL: three cases. ( d ). Velocity of PD1-positive T cells grouped according to diagnosis of lymphadenitis, mature B-cell lymphomas and Hodgkin lymphomas. Each dot represents the mean from one movie. * p < 0.05, ** p < 0.01, Kruskal–Wallis test with Dunn’s post-test for multiple comparisons. ( e ). Velocity of PD1-positive T cells according to lymphoma entities. ** p < 0.01, *** p < 0.001, Kruskal–Wallis-Test with Dunn´s post-test for multiple comparisons. Each dot represents the mean from one movie. Lymphadenitis: 5 cases, AITL and MCL: one case, MGZL, DLBCL, FL and NLPHL: two cases, cHL: three cases. ( f ). Velocity of CD30-positive lymphoma cells compared with CD30-positive reactive bystander cells in CD30-negative lymphomas and lymphadenitis (* p < 0.05, unpaired t -test). Each dot represents the mean from one movie.

    Article Snippet: Live vibratome sections were stained for 15 min at 37 °C with the following antibodies: Alexa Fluor 647–anti-human PD-1 (clone EH12.2H7; BioLegend, San Diego, CA, USA), Alexa Fluor 647–anti-human CD30 (clone CD30/412, Novus Biologicals, Centennial, CO, USA), Alexa Fluor 488–anti-human PD-1 (clone EH12.2H7; BioLegend), Alexa Fluor 647–anti-human CD3 (clone UCHT1; BD Biosciences), Brilliant Violet 421–anti-human CD3 (clone UCHT1; BioLegend), Alexa Fluor 488–anti-human CD19 (clone HIB 19; BioLegend), Pacific Blue–anti-human CD20 (clone 2H7; BioLegend), Alexa Fluor 555-anti-human CD20 (polyclonal rabbit antibody; Bioss Antibodies, Woburn, MA, USA), and Alexa Fluor 555-anti-human CD19 (polyclonal rabbit antibody; Bioss Antibodies).

    Techniques: Biomarker Discovery

    Cell tracks according to different lymphoma types superimposed on fluorescence images. ( a – c ) Tracks of the tumor cells of mantle cell lymphoma ( a ), NLPHL ( b ) and MGZL ( c ) in CD20- or CD30-immunostaining, as indicated. Color of tracks corresponds to the observed velocity as indicated in the scale. ( d – f ) Tracks of the bystander T cells of the same cases: mantle cell lymphoma ( d ), NLPHL ( e ) and MGZL ( f ) in PD1-staining. Color of tracks corresponds to the observed velocity as indicated in the scale. ( g ) HE staining (200x) of the mantle cell lymphoma from ( a , d ). ( h ) HE staining (200x) of the NLPHL from ( b , e ). ( i ) HE staining (200×) of the MGZL from ( c , f ).

    Journal: Cancers

    Article Title: Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas

    doi: 10.3390/cancers13205208

    Figure Lengend Snippet: Cell tracks according to different lymphoma types superimposed on fluorescence images. ( a – c ) Tracks of the tumor cells of mantle cell lymphoma ( a ), NLPHL ( b ) and MGZL ( c ) in CD20- or CD30-immunostaining, as indicated. Color of tracks corresponds to the observed velocity as indicated in the scale. ( d – f ) Tracks of the bystander T cells of the same cases: mantle cell lymphoma ( d ), NLPHL ( e ) and MGZL ( f ) in PD1-staining. Color of tracks corresponds to the observed velocity as indicated in the scale. ( g ) HE staining (200x) of the mantle cell lymphoma from ( a , d ). ( h ) HE staining (200x) of the NLPHL from ( b , e ). ( i ) HE staining (200×) of the MGZL from ( c , f ).

    Article Snippet: Live vibratome sections were stained for 15 min at 37 °C with the following antibodies: Alexa Fluor 647–anti-human PD-1 (clone EH12.2H7; BioLegend, San Diego, CA, USA), Alexa Fluor 647–anti-human CD30 (clone CD30/412, Novus Biologicals, Centennial, CO, USA), Alexa Fluor 488–anti-human PD-1 (clone EH12.2H7; BioLegend), Alexa Fluor 647–anti-human CD3 (clone UCHT1; BD Biosciences), Brilliant Violet 421–anti-human CD3 (clone UCHT1; BioLegend), Alexa Fluor 488–anti-human CD19 (clone HIB 19; BioLegend), Pacific Blue–anti-human CD20 (clone 2H7; BioLegend), Alexa Fluor 555-anti-human CD20 (polyclonal rabbit antibody; Bioss Antibodies, Woburn, MA, USA), and Alexa Fluor 555-anti-human CD19 (polyclonal rabbit antibody; Bioss Antibodies).

    Techniques: Fluorescence, Immunostaining, Staining

    Cell–cell contacts between tumor and bystander cells. ( a ) Number of cell–cell contacts per movie between tumor cells (CD20 or CD30 as indicated) and PD1-positive T cells (for AITL PD1-positive tumor cells and CD20-positive B cells). Each dot represents the mean from one movie. Lymphadenitis: 4 cases, AITL, DLBCL, NLPHL and MCL: one case, MGZL: two cases, cHL: three cases. ( b ) Duration of cell–cell contacts between tumor (CD20 or CD30 as indicated) and PD1-positive T cells (for AITL PD1-positive tumor cells and CD20-positive B cells, * p < 0.05, Kruskal–Wallis test with Dunn’s post-test for multiple comparisons). Each dot represents the mean from one movie. Lymphadenitis: 4 cases, AITL, DLBCL, NLPHL and MCL: one case, MGZL: two cases, cHL: three cases.

    Journal: Cancers

    Article Title: Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas

    doi: 10.3390/cancers13205208

    Figure Lengend Snippet: Cell–cell contacts between tumor and bystander cells. ( a ) Number of cell–cell contacts per movie between tumor cells (CD20 or CD30 as indicated) and PD1-positive T cells (for AITL PD1-positive tumor cells and CD20-positive B cells). Each dot represents the mean from one movie. Lymphadenitis: 4 cases, AITL, DLBCL, NLPHL and MCL: one case, MGZL: two cases, cHL: three cases. ( b ) Duration of cell–cell contacts between tumor (CD20 or CD30 as indicated) and PD1-positive T cells (for AITL PD1-positive tumor cells and CD20-positive B cells, * p < 0.05, Kruskal–Wallis test with Dunn’s post-test for multiple comparisons). Each dot represents the mean from one movie. Lymphadenitis: 4 cases, AITL, DLBCL, NLPHL and MCL: one case, MGZL: two cases, cHL: three cases.

    Article Snippet: Live vibratome sections were stained for 15 min at 37 °C with the following antibodies: Alexa Fluor 647–anti-human PD-1 (clone EH12.2H7; BioLegend, San Diego, CA, USA), Alexa Fluor 647–anti-human CD30 (clone CD30/412, Novus Biologicals, Centennial, CO, USA), Alexa Fluor 488–anti-human PD-1 (clone EH12.2H7; BioLegend), Alexa Fluor 647–anti-human CD3 (clone UCHT1; BD Biosciences), Brilliant Violet 421–anti-human CD3 (clone UCHT1; BioLegend), Alexa Fluor 488–anti-human CD19 (clone HIB 19; BioLegend), Pacific Blue–anti-human CD20 (clone 2H7; BioLegend), Alexa Fluor 555-anti-human CD20 (polyclonal rabbit antibody; Bioss Antibodies, Woburn, MA, USA), and Alexa Fluor 555-anti-human CD19 (polyclonal rabbit antibody; Bioss Antibodies).

    Techniques: